In this study, we describe the use of nuclease-resistant molecular beacons (MBs) for the real-time detection of coxsackievirus B6 replication in living Buffalo green monkey kidney (BGMK) cells via Tat peptide delivery. A nuclease-resistant MB containing 2-Omethyl RNA bases with phosphorothioate internucleotide linkages was designed to specifically target an 18-bp 5 noncoding region of the viral genome. For intracellular delivery, a cell-penetrating Tat peptide was conjugated to the MB by using a thiol-maleimide linkage. Presence of the Tat peptide enabled nearly 100% intracellular delivery within 15 min. When the conjugate was introduced into BGMK cell monolayers infected with coxsackievirus B6, a discernible fluorescence was observed at 30 min after infection, and as few as 1 infectious viral particle could be detected within 2 h. The stability and the intracellular delivery properties of the modified MBs enabled real-time monitoring of the cell-to-cell spreading of viral infection. These results suggest that the Tatmodified, nuclease-resistant MBs may be powerful tools for improving our understanding of the dynamic behavior of viral replication and for therapeutic studies of antiviral treatments.
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detection ͉ infectious diseases ͉ real time R eal-time detection of mRNA in living cells is essential to provide information on the dynamics of RNA expression and localization and can be an important tool for advancement in disease pathophysiology, drug discovery, and medical diagnostics. In particular, the ability to monitor the real-time replication of viruses in living cells is vital for the rapid detection of viral infection and an understanding of viral pathogenesis.
Among the technologies currently under development for gene detection in living cells, perhaps the most promising one is molecular beacons (MBs). MBs are single-stranded oligonucleotide probes possessing a stem-loop structure; they are double labeled with a fluorophore at one end and a quencher at the other (1). These probes are specific for a target nucleotide sequence and produce fluorescence upon target binding. The spontaneous hybridization between MBs and their target sequences is highly specific and can even distinguish a single nucleotide mismatch (2) (3) (4) . Recently, MBs have been used to detect the presence of viral RNA in infected cells, with positive responses to even a single infectious viral particle (5) . However, the long-term, real-time monitoring of viral RNA in living cells has not been possible because of the relatively short half-life (Ϸ30 min) of MBs due to endogenous nuclease degradation, resulting in false-positive signals (6, 7) . It has been shown that modifications of MBs with 2Ј-Omethyl RNA bases and phosphorothioate internucleotide linkages can be used to significantly improve duplex stability and nuclease resistance (8) (9) (10) (11) (12) (13) . It is easy to envision that such an MB design can be adapted for the real-time monitoring of viral infection.
In addition, real-time monitoring of viral replication using MBs has been hindered by the lack of an efficient and noninvasive method for intracellular delivery. Conventional approaches such as transfection are slow and inefficient. Delivery based on streptolysin O is faster (Ϸ2 h) but can be used only in ex vivo cellular assays. Even microinjection is not suitable for viral detection, because one cannot predict a priori which cells are infected by viruses. Among the many noninvasive intracellular delivery methods, the HIV-1-derived Tat peptide-based method is the most efficient and has been shown to retain the ability to intracellularly deliver various conjugated cargoes (14) (15) (16) . This Tat-based method, when combined with nuclease-resistant MBs, could provide a powerful means for rapid detection and real-time monitoring of viral replication in living cells with high specificity and sensitivity.
By delivering nuclease-resistant MBs into host cells before viral infection and subsequently tracking fluorescent hybrids with viral RNA, we envision that a better understanding of the dynamic behavior of viral replication could be gained through in vivo experiments and could extend to therapeutic studies of antiviral treatments. Herein, we report the utilization of a nuclease-resistant MB conjugated with a Tat peptide to examine the coxsackievirus B6 (CVB6) viral reproductive cycle in living host cells.
Results and Discussion
Design and Characterization of Nuclease-Resistant MB. An MB (MB CVB6-Tat) targeting an 18-bp region of the 5Ј untranslated region of CVB6 was designed. The DNA backbone was modified with sulfur-substituted 2Ј-O-methyl oligoribonucleotides for improved nuclease resistance (17) (18) (19) (20) . A Tat peptide for intracellular delivery was conjugated to the thiol group at the quencher end by using a maleimide group placed at the N terminus of the peptide (Fig. 1A ) (21, 22) . As expected, the modified MBs were highly resistant to nuclease cleavage by DNase I (Fig. 1B) . In contrast, an unmodified MB was susceptible to nuclease degradation, resulting in almost instantaneous increase in fluorescence. The dual modifications had no effect on the hybridization kinetics of the MB, as a rapid increase in fluorescence was observed in the presence of a complementary target (Fig. 1C) .
Unhybridized MB was also introduced into BGMK cells, and no fluorescence was detected during the same 12-h period, again indicating the intracellular resistance of the modified MBs to nuclease attack (Fig. 2B ). In contrast, in the absence of Tat, no internalization of MBs was observed, and fluorescence was detected only in the medium (Fig. 2B ), confirming the effectiveness of the Tat peptide for rapid intracellular delivery. (Fig. 3A) . The higher number of fluorescent cells compared with plaqueforming units is likely due to the fact that not all viruses that infect a cell are necessarily able to complete the replication cycle (23) . This result is also consistent with the higher infectious virus titers observed by using the quantal assay, which is based on the direct microscopic viewing of cells for virus-induced cytopathic effects, rather than the plaque assay (24) . This 2-h detection window is substantially faster than a similar approach reported using cell fixation/permeabilization (16) . It is possible that the rapid and noninvasive intracellular delivery enables hybridization with viral RNA to occur shortly after virus uncoating without the possibility (Fig. 3B) . The number of plaque-forming units can be determined easily by using the correlation obtained after direct counting of fluorescent cells. More importantly, the method can be used to provide rapid quantification of infectious CVB6 dosages within 2 h p.i. compared with the minimum 48-h incubation period for the plaque assay.
Real-Time Monitoring of Cell-to-Cell Spreading of CVB6. The ability to detect infected cells continuously should allow one to follow the spreading of infectious viruses on a real-time basis. To determine whether this was indeed possible, BGMK cells were infected at a very low infection dosage (multiplicity of infection: 0.01 pfu/cell) and monitored continuously by using a fluorescence microscope in a fixed area for 12 h. Fig. 4 In summary, we demonstrated the use of nuclease-resistant, Tat-modified MB for real-time monitoring of viral replication and infection. This method is simple because it requires no cell pretreatment (e.g., fixation/permeabilization) and can be used to study cell-to-cell viral spreading. This method is particularly attractive when applied to viruses with very slow growth, nonlytic viruses, and those that do not produce detectable cytopathic effects in infected cells. Compared with conventional viral plaque assays, which detect infection based on cell lysis only and may take days to weeks to complete, this real-time approach provides an opportunity to study the progress of the entire infectious cycle.
Materials and Methods

BGMK Cell Culture. BGMK cells obtained from American Type Culture Collection
(passages 50 -60) were grown in 400 mL of 1ϫ autoclavable minimum essential medium (AMEM; Irvine Scientific) containing 4 mL of 7.5% NaHCO3, 8 mL of 1 M Hepes, 4 mL of nonessential amino acids (NEAA; Gibco-BRL), 10 mL of A/B-L (1,000 units/mL penicillin, 1,000 units/mL streptomycin, 2 mg/mL kanamycin, 2,000 units/mL nystatin, 80 mM L-glutamine), and 40 mL of FBS (Sigma-Aldrich) at 37°C in a 5% CO2 atmosphere. PBS [1ϫ PBS ϭ 0.01 M phosphate (pH 7.4), 0.138 M NaCl, and 2.7 mM KCl] and Tris-buffered saline solution [1ϫ TBSS ϭ 0.05 M Tris (pH 7.4), 0.28 M NaCl, 10 mM KCl, and 0.82 mM Na 2HPO4] were used for washing steps in the plaque assay and MB analysis, respectively. Virus Preparation. Virus stocks of CVB6 Schmitt strain (ATCC VR-155) were allowed to proliferate on BGMK cells for 2 days at 37°C in a 5% CO2 atmosphere and collected by freeze-thawing (3 times) infected flasks demonstrating Ͼ80% lysis and extracting the cell lysate with chloroform. The CVB6 virus stock was stored at Ϫ80°C. Plaque Assay. The CVB6 virus stock was thawed, and then a series of 10-fold serial dilutions in 1ϫ PBS were prepared. Confluent, 1-day-old BGMK cell monolayers in 12-well, 22.1-mm dishes (Costar; Corning) were infected with 1 mL of virus dilution. After 90 min of adsorption at room temperature, the solutions were aspirated, and 1 mL of 100 mL of 2% carboxymethylcellulose (CMC) sodium salt (Sigma-Aldrich) containing 100 mL of 2ϫ AMEM (Irvine Scientific) with 2 mL of 7.5% NaHCO3, 4 mL of 1M Hepes, 2 mL of NEAA, 5 mL of A/B-L, and 4 mL of FBS (Sigma-Aldrich) was added into each well. After 2 days of incubation at room temperature, the CMC overlay was removed, and the cells were treated with 0.8% crystal violet/3.7% formaldehyde solution overnight. Excess stain was removed by washing with de-ionized water and the virus plaques were counted.
Design of Nuclease-Resistant MB. MB CVB6 was designed on the basis of an alignment of the sequences of enterovirus strains obtained from GenBank database. The DNA folding program mfold (www.bioinfo.rpi.edu/) and IDT SciTools (www.idtdna.com/SciTools/SciTools.aspx) were used to predict the thermodynamic properties and the secondary structures of MBs. MB CVB6 5Ј-6-FAM (fluorescein)-GCCGCTCGCATTCAGGGGCCGGAGAGC/thiol-dG/GC-DABCYL-3Ј [stem sequence is underlined; DABCYL is 4-(4-dimethylaminophenylazo)benzoic acid] possessing a 2Ј-O-methylribonucleotide backbone with phosphorothioate internucleotide linkages was synthesized (TIB Molbiol) to be specifically hybridized to an 18-bp region of the 5Ј untranslated region of the enterovirus genome. The thiol group on the quencher end is for the reaction with a maleimide group attached to the N terminus of the Tat peptide to form a thiol-maleimide bridge. MB CVB6 was suspended in 100 mM Tris⅐HCl (pH 8.0) buffer containing 1 mM MgCl2 to make the concentration 100 M for the subsequent studies. and cultured to Ͼ90% confluence. After removal of the incubation medium, the cell monolayer was washed twice with 1ϫ TBSS. To facilitate determining the efficiency of Tat peptide-mediated intracellular delivery, nonconjugated MB CVB6 or MB CVB6-Tat was mixed with complementary oligonucleotides (5Ј-CTCCGGCCCCTGAATGCG-3Ј) to the loop region at an MB/oligonucleotide molar ratio of 1:1. BGMK cells were incubated at 37°C in the dark with 1ϫ Leibovitz L-15 medium (Invitrogen) containing either preformed nonconjugated MB CVB6 hybrids or MB CVB6-Tat hybrids at MB concentrations of 0.5, 1, or 2 M. The Leibovitz L-15 contains no phenol red to eliminate autofluorescence and to increase optical transmission. To record the image, the chamber well was placed on the Zeiss Axiovert 40 CFL inverted fluorescence microscope stage and was marked to permit the repeated observation of the chosen region in the cell monolayer. As soon as the positive fluorescent signals were observed inside the cells, the chamber well was kept on the microscope stage instead of returning it to the 37°C incubator. All assays were carried out over a period of 12 h, and the fluorescence images were taken at intervals of 5 min.
Progression of Viral Infection in Living Cells. BGMK cells were cultured to Ͼ90% confluence in the 8-well Lab-Tek Chambered Coverglass (Fisher Scientific) at 37°C in 5% CO 2 atmosphere. After incubation for predetermined time periods, the slides were removed from the 37°C incubator, and the growth medium was aspirated. Following 2 washes with 1ϫ TBSS, the cells were incubated with 1 M MB CVB6-Tat in 1ϫ Leibovitz L-15 medium (Invitrogen) at 37°C in the dark for 30 min. Without washing away the incubation medium, the chamber wells were oriented on the microscope stage; the cells were infected with 10-fold virus dilutions in 1ϫ Leibovitz L-15 medium and were observed under the Zeiss Axiovert 40 CFL inverted fluorescence microscope at room temperature for 12 h. The fluorescence images were recorded at intervals of 5 min.
Fluorescence Microscopy and Image Processing. Living cell imaging was performed on a Zeiss Axiovert 40 CFL inverted microscope equipped with a 12-V, 35-W halogen lamp (for the phase-contrast images) and an HBO 50 W/AC mercury lamp (for the fluorescence images). The objectives used were a 5ϫ/0.12 A-Plan, a 10ϫ/0.25 A-Plan, a 20ϫ/0.50 EC Plan-NEOFLUAR, and a 40ϫ/0.50 LD A-Plan (Zeiss). 6-FAM-labeled fluorescent hybrids were detected by using a filter set consisting of a D480/30-nm exciter, a D535/40-nm emitter, and a 505-dichroic long pass beam splitter (Chroma Technology). Images were acquired by using a ProgRes MF scan Monochrome CCD camera (Jenoptik). Both phase-contrast and fluorescence images were analyzed by using Image-Pro PLUS analysis software (Media Cybernetics). All settings for image processing were kept constant, and the exposure time for image capture was adjusted, if necessary, to maintain output levels similar to those observed under the fluorescence microscope.
Enumeration of Fluorescent Cells. To calculate the infected cells (fluorescent cells) in each chamber well, 30 fields within the well were randomly chosen, and the fluorescence images were collected at 10ϫ magnification. The number of fluorescent cells within the area was counted by Image-Pro PLUS analysis software.
